The main side effects of<unk>  for uterine fibroids include abnormal uterine bleeding (24.6–48.6% vs. 6.3% for placebo), hot flashes (42.8–45.5% vs. 0% for placebo), heavy menstrual bleeding (12.1–49.3% vs. 9.4% for placebo), headache (12.3–15.2%), and excessive sweating (9.4–15.2% vs. 0% for placebo). In addition, decreased bone mineral density occurs with<unk>  (21.7% decrease by week 12, 24.4% decrease by week 24).
Relugolix
Elagolix
Lifitegrast
Deflazacort
Maralixibat chloride
Sufugolix
Seratrodast
Naloxegol